August 2012

Surrey CRC awarded MHRA Phase 1 Supplementary Accreditation

1 August 2012

We are delighted to announce that Surrey Clinical Research Centre has been awarded MHRA Phase 1 Standard and Supplementary Accreditation as of 1 August 2012. We are one of only two non-commercial centres to achieve this accreditation status which enables us to carry out clinical trials with compounds at all levels of risk. Furthermore, it demonstrates the quality of our work which is underpinned by a team of well-trained and highly experienced staff.